Status:
RECRUITING
Tools for Reducing Inequity in Acute Leukemia (TRIAL): Beta Testing
Lead Sponsor:
Dana-Farber Cancer Institute
Collaborating Sponsors:
American Society of Clinical Oncology
National Cancer Institute (NCI)
Conditions:
Acute Leukemia
Leukemia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study aims to test the Tools for Reducing Inequity in Acute Leukemia (TRIAL) web-based application that is designed to support participants with acute leukemia by providing information and resour...
Detailed Description
The goal of this single-arm pilot study is to test the TRIAL web application which is designed to reduce inequity in clinical trial enrollment among participants with acute leukemia. The application a...
Eligibility Criteria
Inclusion
- Age 18 or older
- English speaking
- Ability to understand and willingness to sign written informed consent
- Clinical suspicion of acute leukemia
- Admitted to DFCI-affiliated inpatient unit
Exclusion
- Cognitive impairment rendering the individual unable to participate in beta testing
- This will be assessed by focused chart review and consultation with the patients' inpatient care team.
- The following populations will be excluded: adults unable to consent, individuals who are not yet adults (infants, children, teenagers \<18 years old), prisoners.
- Inability to participate in in-person application testing.
- Patients who participated in alpha-testing through protocol 23-404 (Appendix A)
Key Trial Info
Start Date :
April 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2027
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT06907797
Start Date
April 1 2025
End Date
June 30 2027
Last Update
May 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dana-Farber Cancer Institute
Boston, Massachusetts, United States, 02215